Novel Medications for Opiate Detoxification - 4

Yale University logo

Yale University

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: Clonidine

Study type

Interventional

Funder types

Other
Other U.S. Federal agency
NIH

Identifiers

NCT00000279
P50DA009250 (U.S. NIH Grant/Contract)
P50-09250-4
NIDA-09250-4

Details and patient eligibility

About

The purpose of this study is to evaluate novel medications for opiate detoxification.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems